Proshares Ultrashort Nas BioETF
13F holders, Q1 2026 (March 31)4holders
0new positions
0sold out
$8.83avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Proshares Ultrashort Nas Bio in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Susquehanna International Group, LLP ($582K), Tower Research Capital LLC (TRC) ($23K) and Morgan Stanley ($21).
- Company
- Proshares Ultrashort Nas Bio
- CUSIP
- 74347G838
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 38,781 shares bought, net +38,781 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Susquehanna International Group, LLP | 0.00% | Add +129.4% | 65,947 | $582K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +149.0% | 2,649 | $23K |
| Morgan Stanley | 0.00% | Add +100.0% | 2 | $21 |
| UBS Group AG | 0.00% | No change | 1 | $9 |
"% of holder's portfolio" is PROSHARES ULTRASHORT NAS BIO's weight in each manager's 13F, not the share of Proshares Ultrashort Nas Bio the manager owns.